Status:
COMPLETED
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
Lead Sponsor:
Mayo Clinic
Conditions:
Sepsis
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.
Eligibility Criteria
Inclusion
- Providers involved with beta-lactam TDM for critically ill patients
Exclusion
- None
Key Trial Info
Start Date :
October 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04755777
Start Date
October 22 2020
End Date
December 31 2022
Last Update
February 21 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
UF Health Shands
Gainesville, Florida, United States, 32610
2
Mayo Clinic
Rochester, Minnesota, United States, 55902
3
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia, 4029